Author:
Li Aihui,Zhang Rui-Xin,Wang Yi,Zhang Haiqing,Ren Ke,Berman Brian M,Tan Ming,Lao Lixing
Abstract
Abstract
Background
Electroacupuncture (EA) has been reported to produce anti-edema and anti-hyperalgesia effects on inflammatory disease. However, the mechanisms are not clear. The present study investigated the biochemical mechanisms of EA anti-inflammation in a rat model.
Methods
Three experiments were conducted on male Sprague-Dawley rats (n = 7–8/per group). Inflammation was induced by injecting complete Freund's adjuvant (CFA) subcutaneously into the plantar surface of one hind paw. Experiment 1 measured plasma corticosterone (CORT) levels to see if EA regulates CORT secretion. Experiment 2 studied the effects of the adrenal gland on the therapeutic actions of EA using adrenalectomy (ADX) rats. Experiment 3 determined whether a prototypical glucocorticoid receptor antagonist, RU486, affects EA anti-edema. EA treatment, 10 Hz at 3 mA and 0.1 ms pulse width, was given twice, for 20 min each, once immediately after CFA administration and again 2 h post-CFA. Plasma CORT levels, paw thickness, indicative of the intensity of inflammation, and paw withdrawal latency (PWL) were measured 2 h and 5 h after the CFA injection.
Results
EA significantly increased plasma corticosterone levels 2 h (5 folds) and 5 h (10 folds) after CFA administration compared to sham EA control, but EA alone in naive rats and CFA alone did not induce significant increases in corticosterone. Adrenalectomy blocked EA-produced anti-edema, but not EA anti-hyperalgesia. RU486 (15 μl, 15 μg/μl), a prototypical glucocorticoid receptor antagonist, also prevented EA anti-edema.
Conclusion
The data demonstrate that EA activates the adrenals to increase plasma corticosterone levels and suppress edema and suggest that EA effects differ in healthy subjects and in those with pathologies.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine,General Medicine
Reference30 articles.
1. Fitzgerald GA, Fitzgerald GA: Coxibs and cardiovascular disease. New England Journal of Medicine. 2004, 351 (17): 1709-1711. 10.1056/NEJMp048288.
2. Buffum M, Buffum JC: Nonsteroidal anti-inflammatory drugs in the elderly. Pain Management Nursing. 2000, 1 (2): 40-50. 10.1053/jpmn.2000.7779.
3. Stiel D: Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations. American Journal of Therapeutics. 2000, 7 (2): 91-98.
4. Davies NM, Jamali F: COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter. J Pharm Pharm Sci. 2004, 7 (3): 332-336.
5. Cheng X: Chinese Acupuncture and Moxibustion. 1999, Beijing , Foreign Languages Press, 590-
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献